Vorsetuzumab
Vorsetuzumab (Anti-Human CD70 Recombinant Antibody) is a human anti-CD70 antibody. Vorsetuzumab enhances macrophage-related phagocytosis of renal carcinoma cells, shows inhibitory efficacy against Burkitt’s lymphoma[1].
Product Specifications
CAS Number
1165740-62-4
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/vorsetuzumab.html
Purity
99.29
Solubility
10 mM in DMSO
Smiles
[Vorsetuzumab]
Molecular Weight
(146.1 kDa)
References & Citations
[1]Ring NG, et al. Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity. Proc Natl Acad Sci U S A. 2017 Dec 5;114 (49) :E10578-E10585.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSH033994-01 10 µg
Recombinant Human Natural Killer Cell Receptor 2B4/SLAMF4/CD244 (C-Fc)
Sign In for Pricing
View Details PKSH033994-02 50 µg
Recombinant Human Natural Killer Cell Receptor 2B4/SLAMF4/CD244 (C-Fc)
Sign In for Pricing
View Details 
LC400950 20 µg
Oct4 (POU5F1) (NM_002701) Human Over-expression Lysate
Sign In for Pricing
View Details 
